Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine-Reference-Cited by-同舟云学术

Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine

Published:2019-10-31 Issue:6 Volume:39 Page:583-590
ISSN:1533-712X
Container-title:Journal of Clinical Psychopharmacology
language:en
Short-container-title:J Clin Psychopharmacol

Author:

van der Schans Jurjen,Hak Eelko,Postma Maarten,Breuning Laura,Brouwers Jacobus R.B.J.,Ditters Kaspar,Jansen Paul A.F.,Kok Rob M.,Maring Jan G.,van Marum Rob,Mulder Hans,Nanninga Jaap,Oude Voshaar Richard C.,Risselada Arne J.,Vleugel Liesbeth,Stek Max,van Schaik Ron H.N.,Berm Elizabeth J.J.,Wilffert Bob

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference30 articles.

1. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature;Psychol Med,2013

2. Natural course of depressive symptoms in late life. An 8-year population-based prospective study;J Affect Disord,2012

3. Age and anxiety and depressive symptoms: the effect on domains of quality of life;Int J Geriatr Psychiatry,2011

4. Remission onset and relapse in depression. An 18-month prospective study of course for 100 first admission patients;J Affect Disord,2000

5. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity;Pharmacogenomics J,2005

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central Nervous System Medications: Pharmacokinetic and Pharmacodynamic Considerations for Older Adults;Drugs & Aging;2024-05-30

2. Current level of evidence for improvement of antidepressant efficacy and tolerability by pharmacogenomic-guided treatment: A Systematic review and meta-analysis of randomized controlled clinical trials;European Neuropsychopharmacology;2024-04

3. Depressive Disorders;Treatment of Psychiatric Disorders Among Older Adults;2024

4. Most patients with disorders of gut‐brain interaction receive pharmacotherapy with major or moderate drug‐gene interactions;Neurogastroenterology & Motility;2023-12-10

5. Which can Predict the Outcome of Antidepressants: Metabolic Genes or Pharmacodynamic Genes?;Current Drug Metabolism;2023-07